Pharmacists as providers of HIV pre-exposure prophylaxis.
The efficacy of HIV pre-exposure prophylaxis (PrEP) has been demonstrated in four clinical trials to date; however, the success of PrEP is largely dependent on high levels of medication adherence. Due to their extensive experience and expertise in medication adherence counseling, as well as their ability to monitor and manage medication adverse effects and drug-drug interactions, clinical pharmacists are well-equipped to play a key role in effective PrEP utilization. Here we discuss reasons favoring the establishment of a protocol-based, pharmacist-run PrEP clinic.
Kaiser Permanente, Vallejo, CA, USA.
Christine
C
Bruno
Parya
P
Saberi
D000554:Ambulatory Care Facilities; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001291:Attitude of Health Personnel; D002983:Clinical Competence; D003157:Community Pharmacy Services; D003376:Counseling; D004334:Drug Administration Schedule; D004347:Drug Interactions; D016903:Drug Monitoring; D019983:Guideline Adherence; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D055118:Medication Adherence; D010595:Pharmacists; D017410:Practice Guidelines as Topic; D016730:Program Development; D013997:Time Factors
D019380:Anti-HIV Agents